The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Abstract
BACKGROUND & AIMS Previous prognostic scores for transarterial chemoembolization (TACE) were mainly derived from real-world settings, which are beyond guideline recommendations. A robust model for outcome prediction and risk stratification of recommended TACE candidates is lacking. We aimed to develop an easy-to-use tool specifically for these patients. METHODS Between January 2010 and May 2016, 1,604 treatment-naïve patients with unresectable hepatocellular carcinoma (HCC), Child-Pugh A5-B7 and performance status 0 undergoing TACE were included from 24 tertiary centres. Patients were randomly divided into training (n = 807) and validation (n = 797) cohorts. A prognostic model was developed and subsequently validated. Predictive performance and discrimination were further evaluated and compared with other prognostic models. RESULTS The final presentation of the model was "linear predictor = largest tumour diameter (cm) + tumour number", which consistently outperformed other currently available models in both training and validation datasets as well as in different subgroups. The thirtieth percentile and the third quartile of the linear predictor, namely 6 and 12, were further selected as cut-off values, leading to the "six-and-twelve" score which could divide patients into 3 strata with the sum of tumour size and number ≤6, >6 but ≤12, and >12 presenting significantly different median survival of 49.1 (95% CI 43.7-59.4) months, 32.0 (95% CI 29.9-37.5) months, and 15.8 (95% CI 14.1-17.7) months, respectively. CONCLUSIONS The six-and-twelve score may prove an easy-to-use tool to stratify recommended TACE candidates (Barcelona Clinic Liver Cancer stage-A/B) and predict individual survival with favourable performance and discrimination. Moreover, the score could stratify these patients in clinical practice as well as help design clinical trials with comparable criteria involving these patients. Further external validation of the score is required. LAY SUMMARY There is currently no prognostic model specifically developed for recommended or ideal transarterial chemoembolization (TACE) candidates with hepatocellular carcinoma, despite these patients being frequently identified as the best target population in pivotal randomized controlled trials. The six-and-twelve score provides patient survival prediction, especially in ideal candidates of TACE, outperforming other currently available models in both training and validation sets, as well as different subgroups. With cut-off values of 6 and 12, the score can stratify ideal TACE candidates into 3 strata with significantly different outcomes and may shed light on risk stratification of these patients in clinical practice as well as in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
(2010) · University of Twente Research Information · Cited by 6,037
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Bootstrap Methods and Their Application
Loughin, T. M., Davison, A. C., & Hinkley, D. V. (1999) · Journal of the American Statistical Association · doi:10.2307/2669707 · Cited by 5,418
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Llovet, J. M., Ducreux, M. P., Lencioni, R. A., Bisceglie, A. M. D., Dufour, J., Greten, T. F., Raymond, É., Roskams, T., Mazzaferro, V., Bruix, J., et al. (2012) · Cited by 1,488
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
Bruix, J., Raoul, J.-L., Sherman, M., Mazzaferro, V., Bolondi, L., Craxi, A., Galle, P. R., Santoro, A., Beaugrand, M., Sangiovanni, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.014 · Cited by 822
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
Chun, Y. S., Pawlik, T. M., & Vauthey, J.-N. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6025-x · Cited by 812
Lencioni, R., de Baere, T., Soulen, M. C., Rilling, W. S., & Geschwind, J. H. (2016) · Hepatology · doi:10.1002/hep.28453 · Cited by 732
Kudo, M., Chung, H., & Osaki, Y. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300038 · Cited by 700
Yau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Lencioni, R., Llovet, J. M., Han, G., Tak, W. Y., Yang, J., Guglielmi, A., Paik, S. W., Reig, M., Kim, D. Y., Chau, G.-Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.012 · Cited by 694
Self-citationBurroughs, A., Dufour, J.-F., Galle, P., Mazzaferro, V., Piscaglia, F., Raoul, J., Sangro, B., & Bolondi, L. (2013) · Seminars in Liver Disease · doi:10.1055/s-0032-1329906 · Cited by 641
Bootstrap Methods and Their Application
Buckland, S. T., Davison, A. C., & Hinkley, D. V. (1998) · Biometrics · doi:10.2307/3109789 · Cited by 575
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M. W., Sturgess, R., Stubbs, C., Stocken, D. D., Wall, L., Watkinson, A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30156-5 · Cited by 499
MICE: Multivariate Imputation by Chained Equations in R
van Buuren, S., & Groothuis-Oudshoorn, K. (2010) · Utrecht University Repository (Utrecht University) · Cited by 496
Burrel, M., Reig, M., Forner, A., Barrufet, M., Lope, C. R. D., Tremosini, S., Ayuso, C., Llovet, J. M., Real, M. I., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.008 · Cited by 485
Sala, M., Llovet, J. M., Vilana, R., Bianchi, L., Solé, M., Ayuso, C., Brú, C., & Bruix, J. (2004) · Hepatology · doi:10.1002/hep.20465 · Cited by 447
Pinato, D. J., Sharma, R., Allara, E., Yen, C., Arizumi, T., Kubota, K., Bettinger, D., Jang, J. W., Smirne, C., Kim, Y. W., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.008 · Cited by 413
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., Hackshaw, A., Fox, R., Johnson, P., Burroughs, A. K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt247 · Cited by 370
Kudo, M., Han, G., Finn, R. S., Poon, R. T. P., Blanc, J.-F., Yan, L., Yang, J., Lu, L., Tak, W.-Y., Yu, X., et al. (2014) · Hepatology · doi:10.1002/hep.27290 · Cited by 355
Self-citationIavarone, M., Cabibbo, G., Piscaglia, F., Zavaglia, C., Grieco, A., Villa, E., Cammà, C., & Colombo, M. (2010) · Hepatology · doi:10.1002/hep.24644 · Cited by 352
Transarterial chemoembolization: Modalities, indication, and patient selection
Sieghart, W., Hucke, F., & Peck-Radosavljevic, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.010 · Cited by 336
Yin, L., Li, H., Li, A.-J., Lau, W. Y., Pan, Z.-Y., Lai, E. C. H., Wu, M.-C., & Zhou, W.-P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.012 · Cited by 334
Self-citationBolondi, L., Burroughs, A. K., Dufour, J.-F., Galle, P. R., Mazzaferro, V., Piscaglia, F., Raoul, J., & Sangro, B. (2012) · BORIS (University Library Bern) · Cited by 320
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
Tateishi, R., Yoshida, H., Shiina, S., Imamura, H., Hasegawa, K., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., et al. (2005) · Gut · doi:10.1136/gut.2003.035055 · Cited by 273
Prognosis of untreated hepatocellular carcinoma
Giannini, E. G., Farinati, F., Ciccarese, F., Pecorelli, A., Rapaccini, G. L., Di Marco, M., Benvegnù, L., Caturelli, E., Zoli, M., Borzio, F., et al. (2015) · Hepatology · doi:10.1002/hep.27443 · Cited by 250
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Galle, P. R., Tovoli, F., Foerster, F., Wörns, M. A., Cucchetti, A., & Bolondi, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.007 · Cited by 236
Takayasu, K., Arii, S., Kudo, M., Ichida, T., Matsui, O., Izumi, N., Matsuyama, Y., Sakamoto, M., Nakashima, O., Ku, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.021 · Cited by 214
Malagari, K., Pomoni, M., Moschouris, H., Bouma, E., Koskinas, J., Stefaniotou, A., Marinis, A., Kelekis, A., Alexopoulou, E., Chatziioannou, A., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0394-0 · Cited by 208
Hsu, C.-Y., Lee, Y.-H., Hsia, C.-Y., Huang, Y.-H., Su, C.-W., Lin, H.-C., Lee, R.-C., Chiou, Y.-Y., Lee, F.-Y., & Huo, T.-I. (2013) · Hepatology · doi:10.1002/hep.25950 · Cited by 205
Kim, B. K., Kim, S. U., Kim, K. A., Chung, Y. E., Kim, M.-J., Park, M.-S., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, M. D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.022 · Cited by 202
Hucke, F., Pinter, M., Graziadei, I., Bota, S., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., Peck-Radosavljevic, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.002 · Cited by 159
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
Farinati, F., Vitale, A., Spolverato, G., Pawlik, T. M., Huo, T.-L., Lee, Y.-H., Frigo, A. C., Giacomin, A., Giannini, E. G., Ciccarese, F., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002006 · Cited by 145
Chao, Y., Chung, Y., Han, G., Yoon, J., Yang, J., Wang, J., Shao, G., Kim, B. I., & Lee, T. (2014) · International Journal of Cancer · doi:10.1002/ijc.29126 · Cited by 120
Self-citationPark, Y., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Park, Y. E., Park, J. H., Lee, Y. I., Yun, H., et al. (2015) · Liver International · doi:10.1111/liv.12878 · Cited by 108
Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
Venkatesh, S. K., Chandan, V. S., & Roberts, L. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.017 · Cited by 108
Transarterial Chemoembolization and Radioembolization
Salem, R., & Sangro, B. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394142 · Cited by 101
Kim, D. Y., Ryu, H. J., Choi, J., Park, J. Y., Lee, D. Y., Kim, B. K., Kim, S. U., Ahn, S. H., Chon, C. Y., & Han, K. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05089.x · Cited by 93
Kim, J. H., Shim, J. H., Lee, H. C., Sung, K., Ko, H. K., Ko, G., Gwon, D. I., Kim, J. W., Lim, Y., & Park, S. H. (2017) · Liver International · doi:10.1111/liv.13487 · Cited by 92
Refining prognosis after trans‐arterial chemo‐embolization for hepatocellular carcinoma
Cappelli, A., Cucchetti, A., Cabibbo, G., Mosconi, C., Maida, M. F., Attardo, S., Pettinari, I., Pinna, A. D., & Golfieri, R. (2015) · Liver International · doi:10.1111/liv.13029 · Cited by 85
Kim, B. K., Shim, J. H., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, K. M., Lim, Y., Han, K., & Lee, H. C. (2015) · Liver International · doi:10.1111/liv.12865 · Cited by 84
Giannini, E. G., Moscatelli, A., Pellegatta, G., Vitale, A., Farinati, F., Ciccarese, F., Piscaglia, F., Rapaccini, G. L., Marco, M. D., Caturelli, E., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.389 · Cited by 72
Ogasawara, S., Chiba, T., Ooka, Y., Kanogawa, N., Motoyama, T., Suzuki, E., Tawada, A., Azemoto, R., Shinozaki, M., Yoshikawa, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125244 · Cited by 36
Review article: delivering precision oncology in intermediate‐stage liver cancer
Pinato, D. J., Howell, J. A., Ramaswami, R., & Sharma, R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14066 · Cited by 34
Cited by
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, J. M., De Baere, T., Kulik, L., Haber, P. K., Greten, T. F., Meyer, T., & Lencioni, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00395-0 · Cited by 1,044
Therapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Xie, D.-Y., Ren, Z.-G., Zhou, J., Fan, J., & Gao, Q. (2020) · Hepatobiliary Surgery and Nutrition · doi:10.21037/hbsn-20-480 · Cited by 479
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Chang, Y., Jeong, S. W., Young Jang, J., & Jae Kim, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218165 · Cited by 336
Metadata
- Authors
- Wang, Q., Xia, D., Bai, W., Wang, E., Sun, J., Huang, M., Mu, W., Yin, G., Li, H., Zhao, H., Li, J., Zhang, C., Zhu, X., Wu, J., Li, J., Gong, W., Li, Z., Lin, Z., Pan, X., Shi, H., Shao, G., Liu, J., Yang, S., Zheng, Y., Xu, J., Song, J., Wang, W., Wang, Z., Zhang, Y., Ding, R., Zhang, H., Yu, H., Zheng, L., Gu, W., You, N., Wang, G., Zhang, S., Feng, L., Liu, L., Zhang, P., Li, X., Chen, J., Xu, T., Zhou, W., Zeng, H., Zhang, Y., Huang, W., Jiang, W., Zhang, W., Shao, W., Li, L., Niu, J., Yuan, J., Li, X., Lv, Y., Li, K., Yin, Z., Xia, J., Fan, D., & Han, G.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 70
- Issue
- 5
- Pages
- 893-903
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2909659250
- Cited by
- 261
- References
- 60
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.